Questions About Your Current Treatment
Before changing your treatment approach, it’s important to evaluate whether you’ve given your current medication a truly adequate trial. Many factors can affect antidepressant effectiveness, and addressing these first might save you from unnecessarily switching medications or assuming you have treatment-resistant depression when timing or dosage issues are the actual problem.
“Have I been on this medication long enough to evaluate whether it’s working?” Most antidepressants require four to six weeks to reach full effectiveness, and some take up to twelve weeks. However, you should notice some improvement—even subtle changes in sleep, appetite, or energy—within the first month. If you’ve been consistent with your medication for eight weeks or more without any improvement, that’s meaningful information. But if you’ve only been taking it for three weeks and feel impatient, you might just need more time before making changes.
“Am I taking the right dose, or should we consider adjusting it?” Antidepressants have a wide therapeutic range, and what works for one person might be too low for another. Many providers start with a lower dose to minimize side effects, planning to increase if needed. If you’ve been on a low starting dose without improvement, you might benefit from a higher dose rather than a different medication. Ask directly whether your current dose is at the upper end of the therapeutic range or whether there’s room to increase.
“Could anything be interfering with this medication’s effectiveness?” Some medications, supplements, and medical conditions can reduce antidepressant effectiveness. St. John’s Wort, certain pain medications, and even some over-the-counter supplements interact with psychiatric medications. Thyroid problems, vitamin D deficiency, sleep apnea, and undiagnosed medical conditions can cause or worsen depression symptoms regardless of medication. If you haven’t had recent bloodwork or a comprehensive medical evaluation, it’s worth asking whether these factors might be contributing to persistent symptoms.
“Am I actually taking this medication consistently, or am I missing doses more than I realize?” This question is for honest self-reflection more than your provider, though discussing adherence challenges openly helps. Missing doses two or three times a week significantly affects blood levels of medication and reduces effectiveness. If you’re struggling with consistency because of side effects, cost, or simply forgetting, that’s important information that might point toward solutions like once-daily formulations, pill reminders, or addressing side effects rather than assuming the medication isn’t working.
Questions About What Comes Next
If you’ve determined that your current medication has had an adequate trial at an appropriate dose without significant improvement, it’s time to discuss next steps. The American Psychiatric Association recommends asking about the definition of adequate trial, treatment history review, alternative medication classes, and non-medication options when discussing treatment failure (APA, 2020).
“What defines treatment-resistant depression, and do my symptoms meet that criteria?” Understanding whether you have treatment-resistant depression helps frame the conversation about next steps. The clinical definition typically requires failing to respond adequately to at least two different antidepressant medications from different classes, each taken at therapeutic doses for sufficient duration. If you’ve only tried one medication, you haven’t yet met criteria for treatment-resistant depression, which means trying another standard medication is a reasonable next step. But if you’ve cycled through multiple medications, that resistance pattern suggests your depression might benefit from treatments that work through different mechanisms. You can also read more about this in our article on how to advocate for yourself when depression treatment fails.
“What medication classes haven’t I tried yet?” Antidepressants fall into several categories—SSRIs like sertraline, SNRIs like venlafaxine, atypical antidepressants like bupropion, TCAs like nortriptyline, and MAOIs like phenelzine. Each class works slightly differently. If you’ve only tried SSRIs, switching to an SNRI or atypical antidepressant might help. But if you’ve tried multiple classes without benefit, continuing to cycle through similar mechanisms may be less effective than exploring treatments that target completely different brain systems, like glutamate rather than serotonin.
“Should we consider augmentation instead of switching medications?” Augmentation means adding a second medication to boost the first one’s effectiveness rather than stopping the first medication entirely. This strategy works well when you’ve had partial response but haven’t reached remission. Common augmentation approaches include adding lithium, thyroid hormone, or an atypical antipsychotic to your current antidepressant. Your provider can explain the rationale for augmentation versus switching and help you understand the pros and cons of each approach for your specific situation.
“What are my options beyond traditional antidepressants?” If you’ve tried multiple medication classes without adequate response, treatments that work through different mechanisms may be more effective than continuing to adjust serotonin-based medications. FDA-approved options for treatment-resistant depression include SPRAVATO® (esketamine) nasal spray, which targets glutamate systems. IV ketamine therapy, while used off-label for depression, has significant research supporting its effectiveness for treatment-resistant cases. Other approaches like transcranial magnetic stimulation (TMS) or electroconvulsive therapy (ECT) work through different mechanisms entirely. Asking specifically about these options signals to your provider that you’re open to exploring alternatives if standard medications haven’t worked.
Questions About Timeline and Expectations
Managing expectations about how long treatment takes and what improvement looks like helps you stay engaged with treatment rather than giving up prematurely or continuing something that genuinely isn’t working.
“What should improvement look like, and how will we know this is working?” Depression improvement isn’t always a sudden lifting of symptoms. For some people, it starts with better sleep or slightly more energy before mood improves. For others, the crushing weight lifts gradually over weeks. Ask your provider what specific changes might indicate treatment is beginning to work. This gives you concrete things to monitor rather than waiting to feel “completely better” before deciding treatment is effective.
“If we switch medications, how long before we can evaluate whether the new one is working?” Understanding the timeline prevents premature medication switches. If your provider suggests trying a different antidepressant, knowing you’ll need to commit to at least six to eight weeks before making another change helps you tolerate the waiting period. That timeline also helps you recognize when you’ve given something a genuine trial versus when you’re switching too quickly to see results.
“What happens if this next approach doesn’t work either?” Knowing there’s a plan beyond the current attempt reduces the anxiety of “what if this doesn’t work?” Your provider should be able to outline several additional options, whether that’s trying another medication class, considering augmentation strategies, exploring alternative treatments, or referring to a specialist who focuses on treatment-resistant cases. The point isn’t to plan for failure, but to reassure yourself that options remain even if this particular attempt isn’t successful.
Questions About Therapy and Lifestyle Factors
Medication is just one piece of depression treatment. Exploring whether other factors might enhance treatment effectiveness or whether some barriers are undermining medication effects helps optimize your overall approach.
“Should I be combining medication with therapy, and what type?” Cognitive behavioral therapy (CBT) and interpersonal therapy (IPT) have strong evidence for depression, especially when combined with medication. If you’re only taking medication without therapy, adding therapy might provide the additional support needed for improvement. If you’re already in therapy but not seeing progress, asking whether a different therapeutic approach or a therapist who specializes in treatment-resistant depression might help.
“Are there lifestyle factors that could be affecting my treatment response?” Sleep problems, lack of physical activity, poor nutrition, social isolation, and ongoing stress all affect depression and can reduce medication effectiveness. While these factors aren’t causing your depression in a simplistic “just exercise more” way, they do influence treatment response. If you’re getting four hours of sleep nightly or completely sedentary, addressing those factors alongside medication might enhance treatment effects.
“Could substance use be interfering with my depression treatment?” Alcohol, marijuana, and other substances can significantly impact depression and reduce medication effectiveness. This doesn’t mean you’re an alcoholic or drug addict, but regular use—even moderate drinking—can affect brain chemistry in ways that work against antidepressant effects. An honest conversation about substance use helps determine whether this factor might be contributing to persistent symptoms.
Questions About Alternative Treatments
If standard medication approaches haven’t worked despite adequate trials, asking specifically about alternative treatments helps move the conversation toward options that might be more effective for treatment-resistant depression.
“Am I a candidate for FDA-approved esketamine (SPRAVATO®) treatment?” SPRAVATO® is specifically approved for treatment-resistant depression in adults who haven’t responded to at least two antidepressant trials. If you meet those criteria, asking about SPRAVATO® eligibility helps determine whether this option makes sense for you. Many insurance plans cover SPRAVATO® for eligible patients, making it more accessible than some other alternative treatments. The medication is administered as a nasal spray under medical supervision, with monitoring required for at least two hours after each treatment.
“What’s the difference between IV ketamine and SPRAVATO® for treatment-resistant depression?” Both treatments involve ketamine-related compounds that work on glutamate systems rather than serotonin. SPRAVATO® (esketamine) is FDA-approved and often insurance-covered, while IV ketamine is used off-label and typically requires private pay. IV ketamine has more research history and some patients prefer the controlled infusion method, while others prefer the convenience and insurance coverage of SPRAVATO®. Understanding the practical and clinical differences helps you make informed decisions about which approach might work better for your situation.
“Given my treatment history, what would you recommend as the most promising next step?” This open-ended question lets your provider synthesize everything they know about your case and offer their clinical judgment about the most effective path forward. Different providers have different philosophies about treatment-resistant depression, and their recommendations might include medication adjustments, alternative treatments, specialist referrals, or combined approaches. Asking for their specific recommendation—and the reasoning behind it—helps you understand the strategy rather than just following instructions.
Preparing for Productive Conversations
Before your appointment, write down specific examples of persistent symptoms: “I still can’t concentrate at work,” “I’ve had suicidal thoughts twice this week,” “I feel emotionally flat all the time.” Concrete examples help your provider assess symptom severity more accurately than vague statements like “I don’t feel better.”
Bring a list of all medications you’ve tried, including doses, duration, and why you stopped each one. If you don’t remember details, that’s okay—your provider can access records—but whatever information you have helps. Include over-the-counter supplements, as some interact with psychiatric medications.
Consider tracking your symptoms for two weeks before your appointment. Note mood, energy, sleep quality, and any particularly difficult days. Patterns in this tracking can reveal whether symptoms are constant or fluctuating, whether certain factors make things worse, and whether you’re actually experiencing subtle improvements you haven’t consciously noticed.
The board-certified emergency medicine physicians at Allevate Health in Princeton have over 18 years of experience having these exact conversations with patients whose depression hasn’t responded to standard treatments. Their background in emergency medicine means they’re skilled at quickly assessing complex situations and determining when patients need alternative approaches beyond conventional medication adjustments. They offer complimentary consultations where you can discuss your treatment history in detail and explore whether alternative treatments like IV ketamine therapy or SPRAVATO® might be appropriate for your situation.
If depression treatment isn’t working despite your best efforts, those specific questions can help you and your provider develop a clear plan forward. Whether that means adjusting your current medication, trying a different class, exploring augmentation strategies, or considering alternative treatments, having a structured conversation ensures you’re making informed decisions rather than continuing something that isn’t helping. Call (640) 252-9785 to schedule a complimentary consultation at Allevate Health and discuss your treatment options with physicians who specialize in treatment-resistant depression.
FAQ Section
Q: How many antidepressants should I try before considering alternative treatments?
A: The clinical definition of treatment-resistant depression typically requires failing to respond to at least two different antidepressants from different classes at adequate doses for sufficient duration (usually 4-6 weeks each). However, the number matters less than whether you’ve exhausted standard approaches. If you’ve tried three or four different medication classes without benefit, exploring alternatives like ketamine therapy or SPRAVATO® may be more productive than continuing to cycle through similar medications.
Q: Should I see a psychiatrist instead of my primary care doctor for depression treatment?
A: If you’ve tried multiple antidepressants without success, consulting a psychiatrist—especially one who specializes in treatment-resistant depression—is often beneficial. Psychiatrists have more extensive training in psychopharmacology and experience managing complex medication regimens. However, your primary care doctor can refer you to appropriate specialists and may be able to initiate some changes before that referral.
Q: Will my insurance cover alternative treatments for treatment-resistant depression?
A: Coverage varies significantly. SPRAVATO® is FDA-approved for treatment-resistant depression and is often covered by insurance when you meet eligibility criteria (at least two failed antidepressant trials). IV ketamine therapy is typically considered off-label and requires private pay, though some clinics offer financing options. TMS is covered by many insurance plans for treatment-resistant depression. Always verify coverage before starting treatment.
Q: How do I know if I should stick with my current medication longer or push for a change?
A: If you’ve been on a medication at a therapeutic dose for eight weeks or more without any improvement—not even subtle changes in sleep, energy, or appetite—that’s a clear sign it’s not working. If you’ve had partial improvement but it plateaued weeks ago, you might benefit from dose adjustments or augmentation rather than switching. The key is whether you’re seeing any trajectory toward improvement or whether you’re completely stuck.
Q: Can I request specific treatments, or do I have to take whatever my doctor suggests?
A: You absolutely can request specific treatments and ask your provider’s opinion about options you’ve researched. Good providers welcome informed patients who take an active role in treatment decisions. However, your provider’s clinical judgment about what’s appropriate for your specific situation matters. If they’re hesitant about a treatment you’re interested in, ask them to explain their reasoning. This creates collaborative decision-making rather than either dictating to the other.
References
American Psychiatric Association. (2020). What to know about treatment-resistant depression. https://www.psychiatry.org/patients-families/depression/what-is-depression
Fava, M., & Davidson, K. G. (1996). Definition and epidemiology of treatment-resistant depression. Psychiatric Clinics of North America, 19(2), 179-200. https://pubmed.ncbi.nlm.nih.gov/8827185/
McIntyre, R. S., Alsuwaidan, M., Baune, B. T., Berk, M., Demyttenaere, K., Goldberg, J. F., Gorwood, P., Ho, R., Kasper, S., Kennedy, S. H., Ly-Uson, J., Mansur, R. B., McAllister-Williams, R. H., Murrough, J. W., Nemeroff, C. B., Nierenberg, A. A., Rosenblat, J. D., Sanacora, G., Schatzberg, A. F., … Maj, M. (2023). Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. Journal of Affective Disorders, 156, 1-7. https://www.sciencedirect.com/science/article/abs/pii/S0165032722012939